Alphatec Holdings, Inc. $ATEC Shares Bought by Squarepoint Ops LLC

Squarepoint Ops LLC lifted its holdings in shares of Alphatec Holdings, Inc. (NASDAQ:ATEC) by 24.0% during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 239,870 shares of the medical technology company’s stock after acquiring an additional 46,349 shares during the quarter. Squarepoint Ops LLC owned 0.16% of Alphatec worth $2,663,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the business. Osterweis Capital Management Inc. purchased a new stake in Alphatec during the 2nd quarter worth approximately $37,000. Nisa Investment Advisors LLC grew its position in shares of Alphatec by 22.4% during the second quarter. Nisa Investment Advisors LLC now owns 5,714 shares of the medical technology company’s stock worth $63,000 after buying an additional 1,045 shares in the last quarter. FORA Capital LLC bought a new stake in shares of Alphatec in the first quarter worth $102,000. PKS Advisory Services LLC acquired a new stake in Alphatec in the first quarter valued at $111,000. Finally, R Squared Ltd bought a new position in Alphatec during the 2nd quarter valued at $114,000. Hedge funds and other institutional investors own 66.35% of the company’s stock.

Alphatec Stock Down 1.0%

NASDAQ:ATEC opened at $19.57 on Thursday. The company has a current ratio of 1.99, a quick ratio of 1.24 and a debt-to-equity ratio of 43.02. The stock has a 50 day moving average of $18.78 and a 200-day moving average of $15.25. The firm has a market capitalization of $2.91 billion, a PE ratio of -18.82 and a beta of 1.08. Alphatec Holdings, Inc. has a 52 week low of $8.69 and a 52 week high of $22.66.

Alphatec (NASDAQ:ATEC) last announced its quarterly earnings results on Thursday, October 30th. The medical technology company reported $0.03 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.06) by $0.09. The company had revenue of $196.50 million during the quarter, compared to the consensus estimate of $182.78 million. The company’s revenue for the quarter was up 30.4% on a year-over-year basis. During the same period last year, the business posted ($0.28) EPS. Analysts predict that Alphatec Holdings, Inc. will post -1.08 EPS for the current year.

Wall Street Analyst Weigh In

A number of equities research analysts have recently issued reports on ATEC shares. Loop Capital set a $25.00 target price on shares of Alphatec in a research note on Wednesday, December 10th. Needham & Company LLC upped their price objective on Alphatec from $16.00 to $22.00 and gave the company a “buy” rating in a research note on Friday, October 31st. Barclays increased their target price on Alphatec from $22.00 to $23.00 and gave the stock an “overweight” rating in a report on Monday, November 3rd. Morgan Stanley set a $23.00 price target on Alphatec in a report on Tuesday, December 2nd. Finally, Lake Street Capital set a $25.00 price objective on Alphatec and gave the stock a “buy” rating in a research note on Friday, October 31st. Nine investment analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $22.45.

Insider Activity

In related news, Director Jeffrey P. Rydin sold 200,000 shares of the stock in a transaction dated Monday, November 3rd. The shares were sold at an average price of $19.32, for a total value of $3,864,000.00. Following the sale, the director owned 385,441 shares of the company’s stock, valued at $7,446,720.12. This trade represents a 34.16% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, major shareholder Squadron Capital Llc sold 250,000 shares of Alphatec stock in a transaction dated Wednesday, November 12th. The shares were sold at an average price of $20.80, for a total transaction of $5,200,000.00. Following the completion of the sale, the insider owned 11,145,045 shares in the company, valued at approximately $231,816,936. This represents a 2.19% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last three months, insiders sold 3,135,997 shares of company stock worth $63,844,738. 20.90% of the stock is owned by insiders.

Alphatec Profile

Alphatec Holdings, Inc, a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders in the United States and internationally. It manufactures and sells implants and instruments through third-party suppliers. The company offers Alpha InformatiX product platform, including EOS imaging system that provides full-body imaging; VEA alignment mobile application, which leverages EOS technology to more quickly quantify alignment parameters on a mobile device; SafeOp Neural InformatiX System that automates electromyographic and somatosensory evoked potential monitoring; and Valence, an intra-operative system that integrates navigation and robotics into spine procedures, as well as Sigma Prone TransPsoas (PTP) Access and PTP Patient Positioning Systems.